Evidence map›Paper›PMID 41155111›Full record

ReviewBioengineering (Basel, Switzerland)2025

Generative Adversarial Networks in Dermatology: A Narrative Review of Current Applications, Challenges, and Future Perspectives.

Rosa Maria Izu-Belloso, Rafael Ibarrola-Altuna, Alex Rodriguez-Alonso

Abstract readReview
In one paragraph

Review in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Sustaining High Reliability Amid Artificial Intelligence Adoption in Oncology.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rosa Maria Izu-BellosoMedicine Faculty, Hospital Universitario Basurto, 48013 Bilbao, Spain.ORCID 0000-0001-6159-6395
Rafael Ibarrola-AltunaHospital Universitario Galdakao, 48960 Bizkaia, Spain.ORCID 0009-0002-7309-5525
Alex Rodriguez-AlonsoFacultad de Medicina, Universidad del Pais Vasco/EHU, 48940 Leioa, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Generative Adversarial Networks (GANs) have emerged as powerful tools in artificial intelligence (AI) with growing relevance in medical imaging. In dermatology, GANs are revolutionizing image analysis, enabling synthetic image generation, data augmentation, color standardization, and improved diagnostic model training. This narrative review explores the landscape of GAN applications in dermatology, systematically analyzing 27 key studies and identifying 11 main clinical use cases. These range from the synthesis of under-represented skin phenotypes to segmentation, denoising, and super-resolution imaging. The review also examines the commercial implementations of GAN-based solutions relevant to practicing dermatologists. We present a comparative summary of GAN architectures, including DCGAN, cGAN, StyleGAN, CycleGAN, and advanced hybrids. We analyze technical metrics used to evaluate performance-such as Fréchet Inception Distance (FID), SSIM, Inception Score, and Dice Coefficient-and discuss challenges like data imbalance, overfitting, and the lack of clinical validation. Additionally, we review ethical concerns and regulatory limitations. Our findings highlight the transformative potential of GANs in dermatology while emphasizing the need for standardized protocols and rigorous validation. While early results are promising, few models have yet reached real-world clinical integration. The democratization of AI tools and open-access datasets are pivotal to ensure equitable dermatologic care across diverse populations. This review serves as a comprehensive resource for dermatologists, researchers, and developers interested in applying GANs in dermatological practice and research. Future directions include multimodal integration, clinical trials, and explainable GANs to facilitate adoption in daily clinical workflows.

Indexed as

artificial intelligencedeep learningdermatologyGANmedical imagingsegmentationskin lesionsStyleGANsynthetic images

Identifiers

PMID41155111
PMCPMC12561755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.